PRESS RELEASE published on 08/31/2023 at 19:43, 1 year 2 months ago Hiring of Jochen Rahner as Director Finance, IR and IT to succeed CFO Marek Hahn
PRESS RELEASE published on 08/14/2023 at 12:17, 1 year 3 months ago Q2/2023: Revenue growth in all regions (+8 %) and adjusted earnings improvement (EBITDA +21 %)
PRESS RELEASE published on 07/27/2023 at 16:39, 1 year 3 months ago Results of aap Implantate AG's Annual General Meeting underpin support for corporate strategy pursued
PRESS RELEASE published on 07/21/2023 at 18:54, 1 year 4 months ago EQS-Adhoc: No resolution on certain capital measures at the Annual General Meeting
PRESS RELEASE published on 07/20/2023 at 07:30, 1 year 4 months ago Accelerated patient recruitment; adapted study protocol meets expectations for human clinical trial of breakthrough silver antibacterial coating technology
PRESS RELEASE published on 07/18/2023 at 07:30, 1 year 4 months ago US and LATAM businesses continue with double-digit growth; Q2 sales increase of +8%; solid growth of +6% in H1/2023
PRESS RELEASE published on 06/14/2023 at 07:30, 1 year 5 months ago Proposed capital measures in connection with the convening of the Annual General Meeting: Maintaining freedom of action in a macroeconomic environment characterized by high uncertainties
PRESS RELEASE published on 06/13/2023 at 16:51, 1 year 5 months ago EQS-Adhoc: Executive Board proposes in the invitation to the Annual General Meeting various capital measures for resolution
PRESS RELEASE published on 05/25/2023 at 17:52, 1 year 5 months ago aap CFO Marek Hahn ends his Management Board activities at the end of the year; contracts of CEO and COO extended until the end of 2025
PRESS RELEASE published on 05/15/2023 at 10:32, 1 year 6 months ago Q1/2023: Solid start with slight sales growth (+3 %) and unchanged EBITDA; US and LATAM business grow well into double digits
Published on 11/22/2024 at 00:00, 3 hours 25 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 5 hours 20 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 5 hours 35 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 7 hours 10 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 7 hours 15 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 8 hours 24 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 8 hours 49 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 9 hours 26 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 9 hours 33 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 9 hours 33 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 20 hours 27 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 8 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 9 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 19 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
